330 related articles for article (PubMed ID: 16965549)
21. Association study of the Ubiquilin gene with Alzheimer's disease.
Bensemain F; Chapuis J; Tian J; Shi J; Thaker U; Lendon C; Iwatsubo T; Amouyel P; Mann D; Lambert JC
Neurobiol Dis; 2006 Jun; 22(3):691-3. PubMed ID: 16504527
[TBL] [Abstract][Full Text] [Related]
22. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
Aydogan HY; Isbir S; Kurnaz O; Gormus U; Isbir T
In Vivo; 2009; 23(1):155-61. PubMed ID: 19368142
[TBL] [Abstract][Full Text] [Related]
23. CD14 receptor polymorphism and Alzheimer's disease risk.
Combarros O; Infante J; Rodríguez E; Llorca J; Peña N; Fernández-Viadero C; Berciano J
Neurosci Lett; 2005 May 20-27; 380(1-2):193-6. PubMed ID: 15854776
[TBL] [Abstract][Full Text] [Related]
24. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D
Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415
[TBL] [Abstract][Full Text] [Related]
25. The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's disease.
Doğru-Abbasoğlu S; Aykaç-Toker G; Hanagasi HA; Gürvit H; Emre M; Uysal M
Neurol Sci; 2007 Mar; 28(1):31-4. PubMed ID: 17385092
[TBL] [Abstract][Full Text] [Related]
26. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.
Kuo YM; Emmerling MR; Bisgaier CL; Essenburg AD; Lampert HC; Drumm D; Roher AE
Biochem Biophys Res Commun; 1998 Nov; 252(3):711-5. PubMed ID: 9837771
[TBL] [Abstract][Full Text] [Related]
27. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
28. Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker.
Khan TK; Alkon DL
Neurobiol Aging; 2010 Jun; 31(6):889-900. PubMed ID: 18760507
[TBL] [Abstract][Full Text] [Related]
29. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
30. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
32. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
[TBL] [Abstract][Full Text] [Related]
33. Methionine synthase polymorphism is a risk factor for Alzheimer disease.
Beyer K; Lao JI; Latorre P; Riutort N; Matute B; Fernández-Figueras MT; Mate JL; Ariza A
Neuroreport; 2003 Jul; 14(10):1391-4. PubMed ID: 12876480
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol and Alzheimer's disease--is there a relation?
Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I
Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384
[TBL] [Abstract][Full Text] [Related]
35. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
Stojakovic T; Scharnagl H; März W
Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
[TBL] [Abstract][Full Text] [Related]
36. No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Neurosci Lett; 2004 Apr; 360(1-2):25-8. PubMed ID: 15082170
[TBL] [Abstract][Full Text] [Related]
37. Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers.
Lamsa R; Helisalmi S; Herukka SK; Tapiola T; Pirttila T; Vepsalainen S; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2007; 24(2):146-50. PubMed ID: 17622762
[TBL] [Abstract][Full Text] [Related]
38. Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease.
Wollmer MA; Streffer JR; Tsolaki M; Grimaldi LM; Lütjohann D; Thal D; von Bergmann K; Nitsch RM; Hock C; Papassotiropoulos A
Mol Psychiatry; 2003 Jun; 8(6):635-8. PubMed ID: 12851640
[TBL] [Abstract][Full Text] [Related]
39. The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration.
Porcellini E; Calabrese E; Guerini F; Govoni M; Chiappelli M; Tumini E; Morgan K; Chappell S; Kalsheker N; Franceschi M; Licastro F
Neurosci Lett; 2007 Apr; 416(1):66-70. PubMed ID: 17284348
[TBL] [Abstract][Full Text] [Related]
40. [Associations between Ser447Ter gene polymorphism of lipoprotein lipase and atherosclerotic cerebral infarction].
Guan GD; Xu E; Wang XJ; Xu YH; Qiu SD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):519-22. PubMed ID: 17029199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]